组织碎化术作为局部区域性肝癌治疗的发展:从临床前到临床转化
组织碎化术是一种非侵入、非热、非电离的聚焦超声消融技术,通过空化效应破坏靶组织。本文综述临床前小动物和大动物研究及早期临床研究的关键观察与结果,这些研究推动了美国食品药品监督管理局批准其用于肝癌治疗;临床前研究显示其具有组织选择性,对血管和胆管等胶原结构相对保留,且无创特性可能使合并凝血异常或接受抗凝治疗的患者也可接受治疗。
要点
- 组织碎化术是非侵入、非热、非电离的聚焦超声消融技术,通过空化效应破坏靶组织。
- 临床前研究显示组织碎化术具有组织选择性,对血管和胆管等胶原结构相对保留。
- 组织碎化术的无创特性可能使合并凝血异常或接受抗凝治疗的患者也可接受治疗。
核心结论
- 本文综述临床前和早期临床组织碎化术研究的关键观察与结果,这些研究推动了美国食品药品监督管理局批准组织碎化术用于肝癌治疗;深入理解动物模型中的关键发现和生物学效应将促进组织碎化术的临床采用。
研究设计与样本
- 综述,汇总临床前小动物研究、大动物(人肝尺寸)研究及早期临床组织碎化术研究的关键观察与结果。
关键影像表现/征象
- 小动物研究显示组织碎化术可破坏肝脏肿瘤并产生免疫反应。
- 大动物(人肝尺寸)研究进一步优化了该技术以推动临床转化。
- 临床前研究显示组织碎化术具有组织选择性,不同结构组成的组织对空化诱导破坏的阈值不同,血管和胆管等胶原结构相对保留。
- 组织碎化术可形成边界清晰的治疗区,治疗区随时间快速吸收,便于评估治疗反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Histotripsy is the first noninvasive, nonthermal, and nonionizing focused ultrasound ablative therapy that effectively destroys targeted tissue. Histotripsy research began as an early preclinical prototype that eventually underwent small- and large-animal preclinical testing to ensure safe clinical translation to human use. Small-animal studies demonstrated the efficacy of histotripsy in destroying liver tumors and generating immune responses, while large-animal studies in human-sized livers further refined the technology for clinical translation. Preclinical studies revealed that histotripsy is a safe ablative modality that has tissue selectivity, meaning tissues of different structural composition have different thresholds for cavitation-induced destruction, with relative sparing of collagenous structures such as vessels and bile ducts. The noninvasive nature of histotripsy potentially allows for treatment of patients with coagulation abnormalities or those receiving anticoagulation therapy. Additional findings include the creation of well-defined treatment zones that are seen to rapidly resorb over time, a feature allowing for easier treatment response evaluation. This article reviews key observations and results from preclinical and early clinical histotripsy studies leading to U.S. Food and Drug Administration's approval for the treatment of liver cancer. A thorough understanding of the key findings and biologic effects of histotripsy in animal models will facilitate the clinical adoption of histotripsy. Keywords: Ultrasound, Ablation Techniques, Animal Studies, Abdomen/GI, Liver © RSNA, 2025.
引用
- Worlikar T, Loudon N, Khaykin VM, et al. Development of Histotripsy as a Local-Regional Liver Cancer Therapy: Preclinical to Clinical Translation. Radiol Imaging Cancer. 2025. PMID: 40711384. doi:10.1148/rycan.240403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。